The PharmaJet poster (#32), entitled Modulating Immune Responses to mRNA Vaccines Using Needle-Free Delivery Technologies, will be presented by Dr. Carmen Ledesma-Feliciano, DVM, PhD, DACLAM, ...
CHRISTMAS just wouldn’t be Christmas without watching the holiday classic movie, Elf. In November 2024, rumors began to swirl ...
Aqsa Arif, a Pakistani PhD student from the LEJ Nanotechnology Centre at the HEJ Research Institute of Chemistry, University ...
Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ in rare pediatric disease HLHS has achieved more than 80% enrollmentPositive Type C ...
Equillium Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to ...
84th Scientific Sessions supporting TERN-501 in combination with a GLP-1 receptor agonist for obesity Preclinical findings ...
Promega and QuantumCyte have signed a strategic joint marketing agreement to promote automated workflow solutions for ...
Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that key opinion leader (“ KOL ”) collaborators are presenting results ...
The treatment of Lisfranc injuries continues to evolve with time. Meloria Hoskins et al conducted a study to report early ...
Doha, Hamad Bin Khalifa University (HBKU) and Texas A&M University at Qatar (TAMU-Q) successfully hosted the inaugural ...
HUNTINGTON More than 200 students and post-doctoral residents and fellows participated in the 36th annual Marshall University Health Sciences Research Day on Nov. 1 at Marshall University Medical ...
Research reactors, distinct from nuclear power reactors due to their lower power output (typically under 100 MW thermal), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback